Comparison of the immunogenicity of Dukoral® oral cholera vaccine between renal transplant recipient...
Comparison of the immunogenicity of Dukoral® oral cholera vaccine between renal transplant recipients on either a calcineurin inhibitor or mycophenolate – A controlled trial
About this item
Full title
Author / Creator
Publisher
Netherlands: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
•Seroconversion after Dukoral 57% in renal transplant recipients and 81% in controls.•Vaccine response most suppressed by mycophenolate followed by calcineurin inhibitor.•Do not discard oral vaccines in immunosuppressed patients.
The evidence for recommendations regarding vaccination in solid organ transplant recipients is sparse. There is littl...
Alternative Titles
Full title
Comparison of the immunogenicity of Dukoral® oral cholera vaccine between renal transplant recipients on either a calcineurin inhibitor or mycophenolate – A controlled trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2216773940
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2216773940
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2019.04.010
